is glp 1 safe to take GLP-1 Agonists: Using Semaglutide, Tirzepatide, and Orforglipron for Weight Loss and Obesity How Do You Know When

Nauck MA, Homberger E, Siegel EG, Allen RC, Eaton RP, Ebert R, et al

If you have diabetes and are already on medications, your physician will need to evaluate whether compounded semaglutide is appropriate for you and adjust your treatment plan to avoid low blood sugar

The lowest commonly used starting dose is 0.5 mg administered once weekly

The JAMA Internal Medicine study found similar rates of GI adverse events between semaglutide and tirzepatide

When treating such high-risk populations with incretin-based pharmacotherapy for weight loss, preserving muscle mass is crucial for preventing frailty, obesity-related comorbidities, maintaining metabolic health and improving physical function